https://sivelestatinhibitor.co....m/clinicopathologica
Logistic regression models were applied to predict in-hospital mortality (National Inpatient Sample [NIS] cohort) or mortality within 90 days (harmonized cohort), while controlling for baseline variables. The NIS cohort encompassed 198,668 patients, 140% of whom received IV-tPA, and 34% of whom succumbed to hospital-related causes. Within the harmonized study cohort, 7138 patients were analyzed; of those patients, 332% received intravenous tissue plasminogen activator (I